Publications

Latest publication 04/01/2019

Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthen

The beta-adrenergic agonists salbutamol and ephedrine have proven to be effective as therapies for human disorders of the neuromuscular junction,...

Array
(
    [id_prestablog_news] => 1117
    [id_shop] => 1
    [date] => 2019-04-01 00:00:00
    [date_modification] => 2024-02-09 14:15:12
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [prim_key] => 2195
    [id_lang] => 1
    [title] => Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthen
    [paragraph] => Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome
    [content] => 
Authors
GM McMacken, S Spendiff, RG Whittaker, E o'connor et al

 Lab
Hospital of Eastern Ontario Research Institute 401 Smyth Road Ottawa, K1H 8L1
Journal
Human Molecular Genetics
Abstract
The beta-adrenergic agonists salbutamol and ephedrine have proven to be effective as therapies for human disorders of the neuromuscular junction, in particular many subsets of congenital myasthenic syndromes. However, the mechanisms underlying this clinical benefit are unknown and improved understanding of the effect of adrenergic signalling on the neuromuscular junction is essential to facilitate the development of more targeted therapies. Here, we investigated the effect of salbutamol treatment on the neuromuscular junction in the ColQ deficient mouse, a model of end-plate acetylcholinesterase deficiency. ColQ_/_ mice received 7 weeks of daily salbutamol injection, and the effect on muscle strength and neuromuscular junction morphology was analysed. We show that salbutamol leads to a gradual improvement in muscle strength in ColQ_/_ mice. In addition, the neuromuscular junctions of salbutamol treated mice showed significant improvements in several postsynaptic morphological defects, including increased synaptic area, acetylcholine receptor area and density, and extent of postjunctional folds. These changes occurred without alterations in skeletal muscle fibre size or type. These findings suggest that _-adrenergic agonists lead to functional benefit in the ColQ_/_ mouse and to long-term structural changes at the neuromuscular junction. These effects are primarily at the postsynaptic membrane and may lead to enhanced neuromuscular transmission.
BIOSEB Instruments Used
Grip strength test (BIO-GS3)
    [meta_description] => 
    [meta_keywords] => https://academic.oup.com/hmg/advance-article/doi/10.1093/hmg/ddz059/5424977
    [meta_title] => 
    [link_rewrite] => salbutamol-modifies-the-neuromuscular-junction-in-a-mouse-model-of-colq-myasthenic-syndrome
    [actif_langue] => 1
    [read] => 1164
    [count_comments] => 0
    [id] => 1117
    [categories] => Array
        (
            [63] => Array
                (
                    [id_prestablog_categorie] => 63
                    [title] => General muscular system
                    [link_rewrite] => General-muscular-system
                )

            [20] => Array
                (
                    [id_prestablog_categorie] => 20
                    [title] => Muscular system
                    [link_rewrite] => Muscular-system
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [48] => Array
                (
                    [name] => Grip strength test
                    [description_short] => 
An easy way to objectively quantify the muscular strength of mice and rats, and to assess the effect of drugs, toxins, muscular (i.e. myopathy) and neurodegenerative diseases on muscular degeneration. It is widely used in conjunction with the ROTAROD motor coordination test: a normally coordinated rodent will show a decreased latency to fall off the rotating rod if its muscular strength is low. The Grip Strength Test is a must for your research on activity, motor control & coordination, and is particularly well suited for studies on Parkinson's & Huntington's disease.
New features GS4 - 2023: Color display with permanent backlight screen for easier reading, reset by footswitch, Improved battery time, Larger data memory of 500 values, Animal counter, USB port (charging/data transfer)

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/preprod.bioseb.com/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://preprod.bioseb.com/en/activity-motor-control-coordination/48-grip-strength-test.html
                )

        )

)
1